Examining the link between obesity and heart health in patients with hypertrophic cardiomyopathy
Association of Obesity and Cardiovascular Outcomes in Patients With Hypertrophic Cardiomyopathy : a Korean Nationwide Cohort Study
This study looks at how being overweight affects heart health in Asian patients with hypertrophic cardiomyopathy.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 30000 (estimated) |
| Ages | 20 Years and up |
| Sex | All |
| Sponsor | Ajou University School of Medicine Academic / other |
| Locations | 1 site (Suwon, Gyeong-gido) |
| Trial ID | NCT05645939 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the relationship between obesity, measured by BMI and waist circumference, and cardiovascular outcomes in Asian patients diagnosed with hypertrophic cardiomyopathy. Utilizing a nationwide cohort from the Korean National Health Insurance Service, the study analyzes data from patients diagnosed between 2015 and 2020. It collects comprehensive demographic, health, and lifestyle information to assess how obesity impacts clinical outcomes in this specific patient population.
Who should consider this trial
Good fit: Ideal candidates for this study are Asian patients newly diagnosed with hypertrophic cardiomyopathy between 2015 and 2020.
Not a fit: Patients under 20 years old, those diagnosed with hypertrophic cardiomyopathy before 2015, or individuals with cancer may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide insights into how obesity affects heart health in patients with hypertrophic cardiomyopathy, potentially guiding treatment strategies.
How similar studies have performed: While the association between obesity and cardiovascular outcomes has been explored, this specific focus on hypertrophic cardiomyopathy in an Asian population is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients newly diagnosed with HCMP between January 2015 and December 2020 Exclusion Criteria: * Patients aged \<20 years * Patients diagnosed with HCMP before 2015 * Patients with cancer
Where this trial is running
Suwon, Gyeong-gido
- Ajou University School of Medicine — Suwon, Gyeong-gido, Korea, Republic of (Recruiting)
Study contacts
- Study coordinator: Kwang-No LEE
- Email: knlee81@ajou.ac.kr
- Phone: +82-9286-1123
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.